Systemic Dosing of Virus-derived Serpin Improves Survival and Immunothrombotic Damage in Murine Colitis
Zhang, L.; Turk, J. R.; Monder, H.; Woodrow, C. R.; Spaccarelli, L.; Garg, A.; Schlievert, J.; Elmadbouly, N.; Dupati, A.; Kilbourne, J.; Lowe, K. M.; Aliskevich, E.; Satyanarayanan, R. S.; Saju, R.; Hamada, M.; Pinteric, A.; Zanetti, I. R.; Enow, J.; Florsheim, E. B.; Rahman, M.; Irving, J. A.; McFadden, G.; Kong, W.; Lucas, A. R.
Show abstract
Inflammatory bowel disease (IBD) is potentially life-threatening, with risk of bleeding, clotting, infection, sepsis, cancer and toxic megacolon. Systemic and local immune and coagulation dysfunction increase IBD severity. Current treatments are partially effective, but there is no definitive cure. Serine protease cascades activate thrombotic, thrombolytic and complement pathways and are regulated by inhibitors, serpins. Viruses encode proteins evolved from endogenous central regulatory pathways. A purified secreted Myxomavirus-derived serpin, Serp-1, dosed as a systemic anti-inflammatory drug, has proven efficacy in vascular and inflammatory disorders. PEGylated Serp-1 protein (PEGSerp-1) has improved efficacy in lupus and SARS-CoV-2 models. We examined PEGSerp-1 treatment in a mouse Dextran Sodium Sulfate (DSS) colitis model. Prophylactic PEGSerp-1 significantly improved survival in acute severe 4-5% DSS colitis, reducing inflammation and crypt damage in acute 4-5% DSS induced colitis and when dosed as a chronic delayed treatment for recurrent 2% DSS colitis. PEGSerp-1 reduced iNOS+ M1 macrophage invasion, damage to crypt architecture and vascular inflammation with decreased uPAR, fXa, fibrinogen and complement activation. This work supports PEGSerp-1 as a tissue targeting serpin therapeutic.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease 95%
- A Multi-Mineral Intervention To Improve Disease-Related And Mechanistic Biomarkers In Ulcerative Colitis Patients 94%
- High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures 94%
Similar papers in this journal
- Intestinal barrier function in the naked mole-rat: an emergent model for gastrointestinal insights 93%
- Single-cell transcriptomics predict novel potential regulators of acute epithelial restitution in the ischemia-injured intestine 93%
- A Leaky Human Colon Model Reveals Uncoupled Apical/Basal Cytotoxicity in Early Clostridioides difficile Toxin Exposure 92%
Similar papers in this journal
- IL-36/IL-36R Signaling Promotes CD4+ T Cell-Dependent Colitis via Pro-Inflammatory Cytokine Production 95%
- Macrophage-specific NF-kappa B activation dynamics can segregate inflammatory bowel disease patients 93%
- Secondary bile acid lithocholic acid ameliorates colitis-like inflammation in a human intestine-on-chip system 92%
Similar papers in this journal
- The appendix orchestrates T-cell mediated immunosurveillance in colitis-associated cancer 95%
- Loss of intestinal endosome associated protein sorting nexin 27 disrupts epithelial barrier and promotes inflammation 95%
- Genetically induced mouse model for colon-specific epithelial cell tumorigenesis driven by loss of K8 and Apc 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.